April 13, 2017 article Systemic sclerosis The Lancet DOI: 10.1016/s0140-6736(17)30933-9 OpenAlex Authors 0 Author list not loaded yet. Cited by 52 stored of 2,243 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Autoantibodies in systemic sclerosis display a proinflammatory Fc glycosylation signature independent of systemic inflammation 2026 Journal of Autoimmunity article Medicine Systemic Sclerosis and Related Diseases 0 citations Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design 2026 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access 0 citations Exploring the optimal follow-up for systemic sclerosis patients: study protocol for a Dutch multicenter randomized controlled trial 2026 Trials article Medicine Systemic Sclerosis and Related Diseases Open access 0 citations Can we use patient-reported outcomes for remote monitoring in SSc? 2026 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 0 citations Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes 2025 Arthritis & Rheumatology article Medicine Systemic Sclerosis and Related Diseases Open access 3 citations VE/VCO2 at ventilatory threshold and peak VO2 in CPET studies of patients with scleroderma-associated PAH: A systematic review and meta-analyses 2025 Autoimmunity Reviews review Medicine Cardiovascular and exercise physiology Open access 3 citations Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosis 2025 RMD Open article Medicine Systemic Sclerosis and Related Diseases Open access 0 citations Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study 2025 npj Digital Medicine article Medicine Systemic Sclerosis and Related Diseases Open access 6 citations Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study 2025 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 7 citations Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease 2025 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access 10 citations Fibrosis: cross-organ biology and pathways to development of innovative drugs 2025 Nature Reviews Drug Discovery review Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 97 citations The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature 2025 Seminars in Arthritis and Rheumatism review Medicine Systemic Sclerosis and Related Diseases Open access 7 citations Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: A EUSTAR database analysis 2025 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access 4 citations Scleroderma and (Progressive) Systemic Sclerosis 2025 Springer eBooks book-chapter Medicine Systemic Sclerosis and Related Diseases 0 citations Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis 2024 Arthritis & Rheumatology article Medicine Systemic Sclerosis and Related Diseases Open access 9 citations Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis 2024 Arthritis Research & Therapy article Medicine Systemic Sclerosis and Related Diseases Open access 12 citations A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study 2024 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access 8 citations Explainable fully automated CT scoring of interstitial lung disease for patients suspected of systemic sclerosis by cascaded regression neural networks and its comparison with experts 2024 Scientific Reports article Medicine Radiomics and Machine Learning in Medical Imaging Open access 9 citations Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases 2024 Immunological Reviews review Medicine Systemic Sclerosis and Related Diseases Open access 7 citations Detection of Systemic Sclerosis-associated Interstitial Lung Disease by Exhaled Breath Analysis Using Electronic Nose Technology 2024 American Journal of Respiratory and Critical Care Medicine article Medicine Systemic Sclerosis and Related Diseases Open access 5 citations 1–20 of 52 Page 1 / 3 Next → References 0